A p-Tyr42 RhoA Inhibitor Promotes the Regeneration of Human Corneal Endothelial Cells by Ameliorating Cellular Senescence

The development of treatment strategies for human corneal endothelial cells (hCECs) disease is necessary because hCECs do not regenerate in vivo due to the properties that are similar to senescence. This study is performed to investigate the role of a p-Tyr42 RhoA inhibitor (MH4, ELMED Inc., Chunche...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyeon Jung, Hwang, Jin Sun, Noh, Kyung Bo, Oh, Sun-Hee, Park, Jae-Bong, Shin, Young Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295357/
https://www.ncbi.nlm.nih.gov/pubmed/37371916
http://dx.doi.org/10.3390/antiox12061186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295357/
https://www.ncbi.nlm.nih.gov/pubmed/37371916
http://dx.doi.org/10.3390/antiox12061186

Ejemplares similares